Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Growthpoint raises dividend for 2026, warns of weaker growth in 2027
Growthpoint increased distributable earnings per share by 4.3% to 152.6 cents and raised the dividend for 2026 by 7.4% to 133 cents. Net asset value per share rose by 3.8%, the loan-to-value ratio improved to 38.7%; net rental income in South Africa grew like-for-like by 4.4%. For 2027 management now forecasts only 1–3% dividend growth, citing the weak office market in Gauteng, slower reinvestment after disposals and higher financing costs as headwinds. » More on de.investing.com
Growthpoint sells entire 14.2% stake in NewRiver REIT for £50.5 million
Growthpoint Properties Limited has completed the sale of its entire 14.2% stake in NewRiver REIT plc, disposing of 67.4 million ordinary shares at 75 pence each for gross proceeds of £50.5 million. The placing was conducted, according to the announcement, with strong interest from existing and new investors; Panmure Liberum Limited acted as sole bookrunner and settlement is scheduled for 15 August 2025. NewRiver REIT itself will receive no proceeds from the transaction, as it was a sale of Growthpoint’s existing shares. » More on de.investing.com
Growthpoint plans sale of around 47.7 million NewRiver shares at 75p each
Growthpoint Properties Limited will sell approximately 47.7 million ordinary shares of NewRiver REIT plc in an accelerated bookbuild at 75 pence per share, representing most of its previous 14.2% holding. NewRiver has said it intends to buy back up to around 47.7 million of the placed shares; Panmure Liberum is sole bookrunner and NewRiver will receive no proceeds from the secondary placing. The announcement was published as inside information under the UK Market Abuse Regulations, and the final placing result will be announced after the bookbuild is complete. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 327.8m | - |
| Gross profit | 181.17m | - |
| Net profit | 275.82m | - |
| EBITDA | 451.16m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €2.85bn |
Number of shares | 33.86m |
52-week high/low | €102.27 - €82.05 |
Dividend yield | 8.34% |
Dividends TTM | €0.0709 |
Beta | 0.58 |
P/E ratio | 7.03 |
PEG ratio | 0.16 |
P/B ratio | 0.76 |
P/S ratio | 4.11 |
Company profile
Growthpoint is the largest South African primary JSE-listed REIT with a quality portfolio of 440 directly owned properties in South Africa (RSA) valued at R73.4bn, including four hospitals and one medical chambers valued at R2.6bn owned by Growthpoint Healthcare Property Holdings (RF) Limited (GHPH). Growthpoint has a 61.8% shareholding in GHPH. We have a 62.2% interest in ASX-listed Growthpoint Properties Australia Limited (GOZ), which owns 58 properties in Australia valued at R51.8bn and a 52.1% interest in LSE-listed Capital & Regional Plc (C&R), which owns seven properties in the United Kingdom valued at R14.8bn.
| Name | GROWTHPOINT PPTYS |
| CEO | Estienne Konrad de Klerk |
| Headquarters | Sandton,
gp South Africa |
| Website | |
| IPO | 11/04/2018 |
| Employees | 634 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Jnb | GRT.JO |
Pnk | GWWTF |
Frankfurt | G5JA.F |
München | G5JA.MU |